1. Home
  2. VIPS vs PTCT Comparison

VIPS vs PTCT Comparison

Compare VIPS & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vipshop Holdings Limited

VIPS

Vipshop Holdings Limited

HOLD

Current Price

$12.64

Market Cap

6.7B

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$65.79

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIPS
PTCT
Founded
2008
1998
Country
China
United States
Employees
N/A
991
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
5.4B
IPO Year
2012
2006

Fundamental Metrics

Financial Performance
Metric
VIPS
PTCT
Price
$12.64
$65.79
Analyst Decision
Buy
Buy
Analyst Count
4
17
Target Price
$19.58
$80.65
AVG Volume (30 Days)
3.4M
832.7K
Earning Date
05-19-2026
05-07-2026
Dividend Yield
4.38%
N/A
EPS Growth
N/A
264.48
EPS
N/A
0.90
Revenue
N/A
$264,734,000.00
Revenue This Year
$3.79
N/A
Revenue Next Year
$2.05
$17.70
P/E Ratio
$9.00
$73.29
Revenue Growth
N/A
36.19
52 Week Low
$12.02
$57.74
52 Week High
$21.08
$90.87

Technical Indicators

Market Signals
Indicator
VIPS
PTCT
Relative Strength Index (RSI) 35.93 38.95
Support Level $12.02 $63.29
Resistance Level $14.93 $74.30
Average True Range (ATR) 0.28 1.88
MACD 0.01 -0.11
Stochastic Oscillator 36.33 13.13

Price Performance

Historical Comparison
VIPS
PTCT

About VIPS Vipshop Holdings Limited

Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts of 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurement, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners. As of March 31, 2025, Eric Ya Shen, chair and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds a 12.5% interest.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: